June 08, 2026
The plan administration trust created under the Chapter 11 plan of DNA-testing company 23andMe told a Missouri bankruptcy judge Monday that a state court lawsuit brought by the California attorney general over a 2023 data breach violates the terms of the company's confirmed plan.
June 01, 2026
The bankruptcy plan administrator for the genetic testing company formerly known as 23andMe is urging a Missouri bankruptcy court to shut down a lawsuit recently lodged by California's attorney general that seeks to recoup potentially millions of dollars in statutory penalties for the company's alleged security and disclosure failings stemming from a 2023 data breach.
February 02, 2026
US Magnesium secured approval of a $30 million asset sale in its bankruptcy, a judge refused to install a Chapter 11 trustee in Genesis Healthcare's case, and another allowed self-driving vehicle technology company Luminar Technologies to move forward with asset sales that will net its estate $142.54 million.
January 28, 2026
The Missouri judge overseeing former DNA testing company 23andMe's bankruptcy agreed to give final approval to two class action settlements totaling $53.25 million on Wednesday, overruling a handful of objections from class members.
December 08, 2025
A New York federal judge overturned Gol Linhas' Chapter 11 plan over third-party releases. Linqto was cleared to solicit creditor votes on its Chapter 11 plan; AmeriFirst received conditional approval for its disclosure statement despite the Office of the U.S. Trustee's objection. A Missouri judge approved 23andMe's $16.5 million cyber insurance buyback settlement.
December 05, 2025
First Brands will undergo a hearing about a deal regarding its use of lender collateral in its Chapter 11, American Signature will seek the go-ahead on its bidding procedures, and Prospect Medical will make a deferred push to confirm its Chapter 11 plan.
December 03, 2025
A Missouri bankruptcy judge Wednesday agreed to approve a $16.5 million settlement between genetic testing company 23andMe and its insurers, in which the carriers proposed to buy back the unused portion of their cyber coverage.
December 02, 2025
Genetic testing company 23andMe asked a Missouri bankruptcy judge to approve an agreement it reached with a group of cyber insurers, in which those carriers would buy back the remaining portion of their aggregate $25 million in coverage.
December 01, 2025
Former DNA testing company 23andMe has urged a Missouri bankruptcy court to resolve a disagreement between the debtor's unsecured creditors and its shareholders over the rules that will govern the postbankruptcy claims trust proposed in its Chapter 11 plan.
November 19, 2025
Attorneys for former DNA testing company 23andMe urged a Missouri bankruptcy judge Wednesday to approve its Chapter 11 liquidation plan, which resolved objections from states and the U.S. Trustee tied to claim releases.